Company description

Laboserve is an independent, international pharmaceutical company with its own, brand new manufacturing site, headquartered in Athens, Greece. Our purpose-built Liquids Center is supported by in-house QC laboratory, robust quality systems and a team of specialists. It’s this combination of expertise and infrastructure that makes Laboserve your preferred partner for liquid products development and manufacturing utilizing controlled substances. We offer licensing rights and optimized supply agreements for differentiated, tailor-made added value generic products. Amongst other, a proprietary pain management portfolio addressing moderate to severe pain is available as unique presentations and drug combinations. We integrate contract pharmaceutical manufacturing solutions with drug development capabilities to streamline your pathway from the laboratory to the market. Our scientists pair decades of pharmaceutical development expertise with leading-edge technologies to assess, identify and implement the right solutions and help discover added value. We provide applied pharmaceutical research and development services, focused on liquid dosage forms. Laboserve goes beyond the expected, offering accompanying manufacturing capabilities and guidance backed by expertise in product development, technical transfers and scale-up.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Contract Manufacturing |Custom Manufacturing of Dosage Form Drugs |Drops More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 80D91 See our Exhibitor Profile   See full Exhibitor List

News about LABOSERVE

Laboserve is accelerating its global growth

11 Jun 2018

Laboserve is accelerating its global growth

Laboserve is proud to announce that has recently received GMP Certification from the Greek National Medicines Organization (EOF) which is also a member of Mutual Recognition Agreement between FDA and EU, that allows drug inspectors to rely upon information from inspections conducted within each other’s borders.

Read more

Contact information




View all contact information